
Global Franchise Lead, HE&R- HV & ICM (CRM)
Abbott Laboratories
Summary
This position works out of our Sylmar, California location in the Medical Device division. The Global Franchise Lead, HE&R, High Voltage & ICM owns the development and execution of the global value-enablement and evidence strategy for Abbott's HV (ICD/CRT-D, including CSP-enabled high-voltage therapy) and ICM portfolios across all regions - US, EMEA, APAC, and CALA. The role ensures reimbursement, coverage, and economic value are embedded in therapy strategy from early development through global launch and lifecycle.
Job description
The Opportunity
This position works out of our Sylmar, California location in the Medical Device division. The Global Franchise Lead, HE&R, High Voltage & ICM owns the development and execution of the global value-enablement and evidence strategy for Abbott's HV (ICD/CRT-D, including CSP-enabled high-voltage therapy) and ICM portfolios across all regions - US, EMEA, APAC, and CALA. The role ensures reimbursement, coverage, and economic value are embedded in therapy strategy from early development through global launch and lifecycle.
This leader owns the global Market Access evidence generation strategy for the franchise and partners upstream with the owners of the clinical, product-development, and regulatory strategies - R&D, Clinical, Regulatory, and Upstream Marketing - to ensure access, evidence, and economic requirements are reflected in product design and clinical trial strategy, and that Regulatory understands the submission timelines and milestones critical to securing reimbursement in each region.
This role is the payer's voice in the HV and ICM franchises, making sure every product and evidence decision answers what CMS, HTA bodies, and payers will need to cover and pay for it.
What You'll Work On
- Own the global HV & ICM franchise evidence generation strategy across US, EMEA, APAC, and CALA - define the multi-year clinical and economic evidence generation strategies and translate franchise priorities into region- and country-level access objectives.
- Lead the value-enablement and evidence strategy - define the health-economic models, value messages, real-world evidence, and clinical/economic endpoints required to secure coverage, HTA recommendations, and payer adoption across all regions.
- Inform product development and clinical strategy from the access perspective — partnering with R&D, Clinical, and Upstream Marketing to ensure Market Access, evidence, and economic requirements are reflected in product definition, trial endpoints, and the competitive value proposition from early development.
- Align Market Access and Regulatory plans - partnering with Regulatory so they understand the coding, coverage, and payment dependencies critical to reimbursement, and so submission/approval timelines and access milestones are sequenced to enable on-time, funded launches in each region.
- Drive clinical aspects related to coding, coverage, and payment pathway design globally (US CMS rulemaking, CPT/ICD-10-PCS, NTAP/TPT/NCD; ex-US HTA and payment mechanisms) and competitive access positioning for the HV & ICM portfolio.
- Serve as the franchise Market Access advisor to CRM therapy, regional, and commercial leadership, ensuring access and value considerations drive short-, medium-, and long-term global growth and margin planning.
- Build and maintain external relationships with payers, HTA bodies, CMS, procurement groups, professional societies, and KOLs across regions; represent Abbott in policy and coding forums to shape the external access environment.
Required Qualifications
- Bachelor's degree or an equivalent combination of education and work experience.
- Minimum 8 years of related work experience.
- At least 3 years of Market Access and Reimbursement experience for pharmaceutical products, medical devices, or diagnostics.
- Excellent verbal and written communication skills.
- 20% domestic and international travel.
Preferred Qualifications
- Advanced degree (MS/MPH/PharmD/MBA) in health economics, health outcomes, health policy, or related field.
- Overall 12+ years in medical device (or comparable life-sciences) market access, reimbursement, or health economics, including demonstrated global or multi-regional scope.
- Industry-specific experience - cardiac rhythm management, cardiology, electrophysiology, or implantable-device reimbursement.
- Deep expertise across global payment systems and developing clinical evidence strategies to enhance market access strategies globally; experience in health-economic modeling and value-dossier development; demonstrated ability to partner upstream with R&D, Clinical, Regulatory, and Marketing to shape therapy strategy and align regulatory timelines to reimbursement milestones; strong cross-functional influence and executive communication across regions and cultures.
Requirements
- Bachelor's degree or an equivalent combination of education and work experience
- Minimum 8 years of related work experience
- At least 3 years of Market Access and Reimbursement experience for pharmaceutical products, medical devices, or diagnostics
- Excellent verbal and written communication skills
- 20% domestic and international travel
Benefits
- Free medical coverage (HIP PPO)
- Retirement savings plan
- Tuition reimbursement
- Freedom 2 Save student debt program
- FreeU education benefit
- Career development
Company overview
Abbott Laboratories is a global healthcare technology leader founded in 1888 and headquartered in Chicago, Illinois. As an international medtech and pharmaceutical company, Abbott operates in approximately 160 countries worldwide with a workforce of over 115,000 employees. The company is organized into four major business segments: Medical Devices (48% of revenue), Diagnostics (20%), Nutritional Products (19%), and Established Pharmaceutical Products (12%). Abbott's medical devices portfolio includes revolutionary technologies such as the FreeStyle Libre continuous glucose monitoring system for diabetes management, cardiovascular devices like the MitraClip and TriClip for heart valve repair, and neuromodulation systems for chronic pain management. The company's diagnostics division pioneered breakthrough tests including the first licensed HIV blood test in 1985. With a rich history spanning over 135 years, Abbott has consistently been recognized as one of Fortune's World's Most Admired Companies since 1984 and continues to drive innovation in healthcare technology to help people live healthier, fuller lives.